loading

MetLife, Inc. Depositary Shares, each representing a 1/1,000th interest in a share of 5.625% Non-Cumulative Preferred Stock, Series E Stock (METpE) Forecast

The MetLife, Inc. Depositary Shares, each representing a 1/1,000th interest in a share of 5.625% Non-Cumulative Preferred Stock, Series E (METpE) stock price forecast for the next 30 days is generally negative, with an average analyst price target of $20.35, representing a -0.23% decrease from the current price of $20.40. The highest analyst price target is $20.66, and the lowest is $20.05.

Disclaimer: The information on this page is not intended to be financial advice. It is for general information only and should not be used to make any investment decisions. Please consult with a professional financial advisor before making any investment decisions.
12-Month METpE Price Target
Average 19.03 (-6.73% Downside)
loading

Is MetLife, Inc. Depositary Shares, each representing a 1/1,000th interest in a share of 5.625% Non-Cumulative Preferred Stock, Series E (METpE) A Buy Now?

Oscillators
Name Value Action
RSI(14) 49.99 Neutral
STOCH(9,6) 61.13 Neutral
STOCHRSI(14) 100.00 Sell
MACD(12,26) -0.1903 Buy
ADX(14) 32.93 Buy
William %R -9.7222 Sell
CCI(14) 62.03 Neutral
Buy: 2 Sell: 2 Neutral: 3
Summary: Neutral
Moving Averages
Period Simple Exponential
MA10
20.13
Buy
20.18
Buy
MA20
20.26
Buy
20.29
Buy
MA50
20.86
Sell
20.78
Sell
MA100
21.60
Sell
21.42
Sell
MA200
22.53
Sell
22.34
Sell
Buy: 4 Sell: 6 Neutral: 0
Summary: Sell
According to our latest analysis, METpE could be considered a Moderate Sell, with 17 technical analysis indicators signaling 6 Buy signals, 8 signaling Sell signals and 3 Neutral signals. This might not be a good time to consider opening new positions on METpE, as trading bearish markets can be challenging and may result in losses.
  1. RSI (Relative Strength Index): The RSI(14) value of 49.99 indicates that METpE is neither overbought nor oversold. It suggests a neutral sentiment in the short term.
  2. STOCH (Stochastic Oscillator): The STOCH value of 61.13 indicates that METpE is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
  3. STOCHRSI (Stochastic Relative Strength Index): The STOCHRSI value of 100 indicates that METpE is oversold. This suggests that METpE price is at or near the highest level relative to its recent price history.
  4. ADX (Average Directional Index): The ADX value of The ADX value of 32.93 suggests a moderate trend in the market. It indicates that there is more conviction behind the directional movement compared to lower ADX values. You should consider this as a potential opportunity to enter trades in the direction of the trend.
  5. CCI (Commodity Channel Index): A CCI(14) value of A CCI(14) value of 62.03 indicates that METpE is still overbought but not to an extreme extent.

Long-term METpE price forecast for 2025, 2030, 2035, 2040, 2045 and 2050

Based on our analysis about MetLife, Inc. Depositary Shares, each representing a 1/1,000th interest in a share of 5.625% Non-Cumulative Preferred Stock, Series E financial reports and earnings history, MetLife, Inc. Depositary Shares, each representing a 1/1,000th interest in a share of 5.625% Non-Cumulative Preferred Stock, Series E (METpE) stock could reach $10.99 by 2030, $28.86 by 2040 and $62.16 by 2050. See the projected annual prices until 2050 of the MetLife, Inc. Depositary Shares, each representing a 1/1,000th interest in a share of 5.625% Non-Cumulative Preferred Stock, Series E stock below:

  • MetLife, Inc. Depositary Shares, each representing a 1/1,000th interest in a share of 5.625% Non-Cumulative Preferred Stock, Series E (METpE) is expected to reach an average price of $5.5099 in 2035, with a high prediction of $5.282 and a low estimate of $5.0084. This indicates an $-72.99% rise from the last recorded price of $20.40.
  • MetLife, Inc. Depositary Shares, each representing a 1/1,000th interest in a share of 5.625% Non-Cumulative Preferred Stock, Series E (METpE) stock is projected to chart a bullish course in 2040, with an average price target of $28.88, representing an $41.57% surge from its current level. The forecast ranges from a conservative $20.55 to a sky-high $28.86.
  • Our analysts predict MetLife, Inc. Depositary Shares, each representing a 1/1,000th interest in a share of 5.625% Non-Cumulative Preferred Stock, Series E (METpE) to jump 126.94% by 2045, soaring from $46.00 to an average price of $46.30, potentially reaching $45.71. While $46.00 is the low estimate, the potential upside is significant.
  • MetLife, Inc. Depositary Shares, each representing a 1/1,000th interest in a share of 5.625% Non-Cumulative Preferred Stock, Series E (METpE) stock is expected to climb by 2050, reaching an average of $60.74, a $197.75% jump from its current level. However, a wide range of estimates exists, with high and low targets of $62.16 and $61.23, respectively, highlighting the market's uncertainty.

MetLife, Inc. Depositary Shares, each representing a 1/1,000th interest in a share of 5.625% Non-Cumulative Preferred Stock, Series E Stock (METpE) Year by Year Forecast

MetLife, Inc. Depositary Shares, each representing a 1/1,000th interest in a share of 5.625% Non-Cumulative Preferred Stock, Series E Stock (METpE) Price Forecast for 2026

The predicted value for MetLife, Inc. Depositary Shares, each representing a 1/1,000th interest in a share of 5.625% Non-Cumulative Preferred Stock, Series E (METpE) in 2026 is set at an average of $21.75. Estimates vary from a peak of $24.50 to a trough of $18.99, indicating an +6.60% surge from the present price of $20.40.
Month Average Low High Change from today's price
November, 2026 $20.12 $20.05 $20.66 -1.39%
December, 2026 $19.12 $18.99 $20.20 -6.28%

MetLife, Inc. Depositary Shares, each representing a 1/1,000th interest in a share of 5.625% Non-Cumulative Preferred Stock, Series E Stock (METpE) Price Forecast for 2027

For 2027, Stockscan's Analyst expects the average price target for MetLife, Inc. Depositary Shares, each representing a 1/1,000th interest in a share of 5.625% Non-Cumulative Preferred Stock, Series E (METpE) is $18.19, with a high forecast of $20.33 and a low forecast of $16.04. This indicates an -10.86% decrease from the last price of $20.40.
Month Average Low High Change from today's price
January, 2027 $19.35 $18.92 $19.58 -5.15%
February, 2027 $20.00 $19.22 $20.05 -1.96%
March, 2027 $20.16 $19.60 $20.28 -1.17%
April, 2027 $18.43 $18.37 $20.33 -9.68%
May, 2027 $18.82 $17.96 $19.10 -7.75%
June, 2027 $19.03 $18.59 $19.06 -6.71%
July, 2027 $18.04 $18.01 $19.14 -11.56%
August, 2027 $18.71 $17.89 $18.80 -8.30%
September, 2027 $18.15 $18.15 $18.80 -11.04%
October, 2027 $17.71 $17.40 $18.32 -13.19%
November, 2027 $16.47 $16.06 $17.45 -19.25%
December, 2027 $16.71 $16.04 $16.78 -18.07%

MetLife, Inc. Depositary Shares, each representing a 1/1,000th interest in a share of 5.625% Non-Cumulative Preferred Stock, Series E Stock (METpE) Price Forecast for 2028

In 2028, MetLife, Inc. Depositary Shares, each representing a 1/1,000th interest in a share of 5.625% Non-Cumulative Preferred Stock, Series E (METpE) is projected to reach an average price of $15.03, with a high projection of $16.21 and a low estimate of $13.85. This indicates an -26.33% fall from the last price of $20.40.
Month Average Low High Change from today's price
January, 2028 $15.73 $15.65 $16.21 -22.88%
February, 2028 $15.35 $15.21 $16.19 -24.73%
March, 2028 $15.08 $14.60 $15.40 -26.09%
April, 2028 $15.44 $14.93 $15.44 -24.31%
May, 2028 $15.48 $15.26 $15.93 -24.13%
June, 2028 $15.44 $15.44 $16.16 -24.31%
July, 2028 $14.45 $13.85 $15.57 -29.18%
August, 2028 $14.71 $14.28 $15.03 -27.89%
September, 2028 $14.66 $14.55 $15.14 -28.12%
October, 2028 $14.28 $13.94 $14.91 -29.99%
November, 2028 $14.64 $14.26 $14.91 -28.22%
December, 2028 $14.00 $13.90 $14.73 -31.39%

MetLife, Inc. Depositary Shares, each representing a 1/1,000th interest in a share of 5.625% Non-Cumulative Preferred Stock, Series E Stock (METpE) Price Forecast for 2029

The 2029 price forecast for MetLife, Inc. Depositary Shares, each representing a 1/1,000th interest in a share of 5.625% Non-Cumulative Preferred Stock, Series E Stock (METpE) is $11.96 on average, with a high prediction of $14.18 and a low estimate of $9.744. This represents an -41.37% decrease from the previous price of $20.40.
Month Average Low High Change from today's price
January, 2029 $12.73 $12.58 $14.18 -37.58%
February, 2029 $12.73 $12.31 $13.44 -37.61%
March, 2029 $11.48 $11.27 $13.10 -43.73%
April, 2029 $11.31 $11.21 $11.79 -44.56%
May, 2029 $10.41 $10.26 $11.42 -48.95%
June, 2029 $10.75 $10.27 $10.95 -47.31%
July, 2029 $11.60 $10.65 $11.68 -43.14%
August, 2029 $11.79 $11.18 $11.91 -42.20%
September, 2029 $10.16 $10.10 $11.99 -50.21%
October, 2029 $10.68 $9.744 $10.96 -47.65%
November, 2029 $10.99 $10.50 $11.02 -46.11%
December, 2029 $10.35 $9.985 $11.13 -49.24%

MetLife, Inc. Depositary Shares, each representing a 1/1,000th interest in a share of 5.625% Non-Cumulative Preferred Stock, Series E Stock (METpE) Price Forecast for 2030

MetLife, Inc. Depositary Shares, each representing a 1/1,000th interest in a share of 5.625% Non-Cumulative Preferred Stock, Series E Stock (METpE) is expected to reach an average price of $8.3262 in 2030, with a high forecast of $11.02 and a low forecast of $5.6353. This signifies an -59.19% decrease from the last price of $20.40.
Month Average Low High Change from today's price
January, 2030 $10.90 $10.19 $10.99 -46.58%
February, 2030 $10.44 $10.44 $11.02 -48.81%
March, 2030 $10.11 $9.7675 $10.64 -50.46%
April, 2030 $8.998 $8.5597 $9.8722 -55.89%
May, 2030 $9.3417 $8.6148 $9.4117 -54.21%
June, 2030 $6.8237 $6.7637 $7.2965 -66.55%
July, 2030 $6.5997 $6.4285 $7.3858 -67.65%
August, 2030 $6.4246 $5.8926 $6.671 -68.51%
September, 2030 $6.8107 $6.3338 $7.1207 -66.61%
October, 2030 $7.0556 $6.7619 $7.4844 -65.41%
November, 2030 $7.1205 $7.0568 $7.8137 -65.10%
December, 2030 $6.2565 $5.6353 $7.2717 -69.33%
$17.13
price up icon 2.39%
ABX ABX
$7.955
price down icon 2.03%
$21.22
price down icon 0.52%
$9.01
price down icon 0.88%
CIA CIA
$3.34
price down icon 1.18%
$1.11
price down icon 1.77%
Cap:     |  Volume (24h):